Tandem duplications as a genomic scar that provided a measure of HRD in BRCA1-type breast cancers were reported by Qu et al. [45], who developed the tandem duplications score (TD-score) based on the counts of small (<10 kb) tandem duplications. The gene discussed is BRCA1; the disease is breast cancer.